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Host rangeActivated PKR protein regulates downstream anti-viral effects, including inhibition of translation. Thus,
many viruses encode proteins to inhibit PKR. Here, we provide evidence that the vaccinia virus K1 protein, a
host-range protein, possesses this function. First, the expression of the wild-type K1 protein was necessary to
inhibit virus-induced eIF2α phosphorylation, an indirect measure of PKR activation, in RK13 and HeLa cells.
Second, virus-induced eIF2α phosphorylation no longer occurred in PKR-deﬁcient HeLa cells, suggesting PKR
was responsible for vaccinia virus-induced eIF2α modiﬁcation. Third, in normal HeLa cells, K1 protein
expression also prevented virus-mediated PKR phosphorylation (activation). Residues in the C-terminal
portion of the ANK2 region of K1 were identiﬁed as necessary for this inhibitory phenotype. Interestingly,
mutant viruses that failed to inhibit PKR activation, such as S2C#2, also did not replicate in HeLa cells,
suggesting that K1's inhibition of PKR was required for a productive infection. In support of this theory, when
PKR was absent from HeLa cells, there was a modest restoration of viral protein synthesis during S2C#2
infection. However, the increased protein synthesis was insufﬁcient for a productive infection.
© 2009 Elsevier Inc. All rights reserved.Introduction
Vaccinia virus, a member of the poxvirus family, has historically
been used as a vaccine to protect against smallpox, a disease caused by
the closely related variola virus (Moss, 2007). Like all poxviruses,
vaccinia virus is a complex virus that codes for approximately 200
proteins (Moss, 2007). Unique to this family of DNA viruses is a
replication cycle that occurs in the cytoplasm of its host cell. As such,
poxviruses producemany proteins to alter the cellular environment to
allow for viral gene expression, DNA replication, and morphogenesis
(Moss, 2007). Identiﬁcation of suchmechanisms gives insight into the
cellular anti-viral responses that must be inactivated for a productive
infection.
The down-regulation of protein synthesis is a powerful cellular
mechanism to prevent virus replication. One such protein to mediate
this event is eukaryotic translation initiation factor 2 (eIF2α; Proud,
2005). In normal cells, eIF2α remains unphosphorylated and therefore
inactive. Cellular proteins identiﬁed to phosphorylate eIF2α include
PKR, PERK, GCN2, and HRI (Proud, 2005). Once eIF2α is phosphory-
lated on serine residue 51, eIF2α prevents translation initiation,
resulting in a dramatic decrease in protein synthesis (Proud, 2005).na-Champaign, B103 Chemical
na, IL 61801, USA. Fax: +1 217
ll rights reserved.In virus-infected cells, PKR is commonly the mediator of eIF2α
phosphorylation (Garcia et al., 2007). To inhibit this anti-viral
response, poxviruses encode proteins that inhibit the PKR-eIF2α
phosphorylation pathway. For example, the vaccinia virus E3 protein
binds to dsRNA or to PKR to prevent PKR activation (Rivas et al., 1998;
Romano et al., 1998; Sharp et al., 1998; Shors et al., 1997). The cowpox
virus CP77 (CHOhr) protein also inhibits PKR activation during
poxvirus infection (Hsiao et al., 2004). Since CP77 lacks RNA binding
domains, it likely utilizes an inhibitory mechanism distinct from the
E3 mechanism. Yet another vaccinia protein, C7, prevents PKR
phosphorylation (Meng et al., 2008), thereby inhibiting eIF2α
phosphorylation (Najera et al., 2006).
Poxviruses possess host-range genes, a family of genes whose
products are necessary for a productive virus infection (Werden et al.,
2008). The vaccinia virus K1 protein is one such host-range factor
(Perkus et al., 1990). Infection of rabbit kidney epithelial RK-13 cells in
the absence of the K1L ORF results in rapid inhibition of viral and
cellular protein synthesis. The cowpox virus CP77 protein, another
host-range product, is a functional homolog for K1L and substitutes
for the K1 protein to restore vaccinia virus replication in RK13 cells
(Ramsey-Ewing and Moss, 1996). For human cells, such as the human
cervical HeLa cell line, the K1L ORF is also required for virus
replication (Perkus et al., 1990). In contrast to RK13 cells, either the
non-homologous vaccinia C7L or the cowpox CP77 ORFs can
substitute for the K1L ORF to allow for a productive infection in
HeLa cells (Perkus et al., 1990).
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environment conducive for virus replication is unclear. An attractive
hypothesis is that these proteins prevent PKR activation to allow for
viral protein synthesis and viral production. However, the CP77
protein's function to inhibit PKR activation does not completely rescue
virus replication (Hsiao et al., 2004), suggesting that additional
mechanisms are required to ensure virus replication. It was unknown
if the K1 protein, like other host-range proteins, affected PKR
activation and if such a function was responsible for its host-range
function. To test this, the effect of the K1 protein on eIF2α
phosphorylation was assessed during virus infection, under condi-
tions in which the K1 protein was required for replication in RK13 and
HeLa cells. Using this strategy, we identiﬁed a novel eIF2α inhibitory
function for the K1 protein. Further analysis showed that PKR
activation was responsible for eIF2α phosphorylation during vaccinia
infection, with the K1 protein inhibiting PKR activation as its
mechanism for function. The absence of PKR during infection partially
restored viral protein synthesis but did not allow for plaque
formation. Thus, PKR activation may be one of many cellular factors
responsible for inhibiting viral protein synthesis.
Results
The K1 product is required and sufﬁcient to inhibit virus-induced eIF2α
phosphorylation in RK13 cells
The vaccinia K1 product is required for a productive vaccinia
infection of RK13 cells (Perkus et al., 1990). The cowpox virus CP77
protein can compensate for K1 during infection of RK13 cells,
restoring replication proﬁciency of vaccinia viruses lacking the K1L
ORF (Ramsey-Ewing and Moss, 1996). Since the CP77 product was
reported to possess eIF2α inhibitory function (Hsiao et al., 2004), we
queried if the K1 product affected this event. To this end, RK13 cells
were infected with viruses containing or lacking the K1L ORF, and
cytoplasmic extracts were examined by using immunoblotting,
incubating blots with antibodies that recognize eIF2α phosphorylated
at serine 51 (p-eIF2α).
As shown in Fig. 1A, infection of cells with the wild-type Western
Reserve (WR) strain of vaccinia virus prevented eIF2α phosphoryla-
tion, as observed by low levels of p-eIF2α. In contrast, p-eIF2α levelsFig. 1. eIF2α phosphorylation in virus-infected RK13 cells. RK13 cellular monolayers
were mock infected (UN) or infected at an MOI of 10 with either (A) WR or ΔK1L or (B)
MVA or MVA/K1L (MOI=10), and infections proceeded for the indicated times. For
both experiments, a separate set of mock-infected RK13 cells were incubated in
medium containing thapsigargin (thaps) for 4 h as a positive control for eIF2α
phosphorylation. Regardless of treatment, cells were collected and lysed in CE buffer.
Equal amounts of prepared cytoplasmic extracts (20 μg) were electrophoretically
separated by SDS–12% PAGE and transferred to PVDF membranes. Membranes were
probed with antiserum recognizing either the phosphorylated (p-eIF2α) or the
unmodiﬁed forms of eIF2α. Molecular weight markers (MW) are indicated.were increased in cells infected with ΔK1L, a mutant WR virus that
lacks the K1L ORF (Shisler and Jin, 2004), inferring that the presence of
K1 proteins prevented virus-induced eIF2α phosphorylation. The
highest amount of p-eIF2α present during infection, as detected by an
increase in band intensity, occurred at 3 h post-inoculation (pi), and
this form was detectable at all times tested. Treatment of mock-
infected cells with thapsigargin, a known inducer of p-eIF2α (Prostko
et al., 1995), resulted in the presence of a band with the same
mobility. The relative quantities of unmodiﬁed eIF2α for each sample
remained fairly constant, as measured by immunoblotting with
antibodies recognizing only the native (unphosphorylated) form of
eIF2α. Thus, the differences in p-eIF2α levels were not due to protein
degradation. Similar results were observed if rabbit kidney epithelial
LLC-RK1 cells or rabbit lung ﬁbroblast R9AB cells were utilized instead
(data not shown), indicating that the K1 protein's inhibitory effect
occurred in several cell lines. However, p-eIF2α was not detected in
ΔK1L-infected human kidney ﬁbroblast 293 cells or mouse ﬁbroblast
NIH3T3 cells, inferring that the effect of the K1 protein was cell-type
speciﬁc.
Modiﬁed vaccinia Ankara (MVA) is an attenuated vaccinia virus
strain lacking a wild-type K1L ORF (Antoine et al., 1998). Thus, it was
not surprising to observe eIF2α phosphorylation in lysates fromMVA-
infected RK13 cells, with p-eIF2α detected as early as 1 h pi (Fig. 1B).
eIF2α phosphorylation was long lasting since this modiﬁed form of
eIF2αwas still detected in cells collected at 6 h pi. The re-insertion of a
wild-type K1L ORF into MVA (MVA/K1L) resulted in a virus that no
longer triggered eIF2α phosphorylation, suggesting that the K1L ORF
was sufﬁcient to prevent p-eIF2α in RK13 cells. As with Fig. 1A,
unmodiﬁed eIF2α levels in immunoblots were similar for all samples,
inferring that the differences in p-eIF2α levels were not due to
inadequate levels of proteins in each sample. Similar results were also
observed during infection of either LLC-RK1 or R9AB cells (data not
shown).
Mutations in the ankyrin repeat 2 affects the ability of the K1 product to
inhibit eIF2α phosphorylation in RK13 cells
The K1 protein possesses 6 ankyrin (ANK) repeats, motifs
important for protein–protein interactions (Meng and Xiang, 2006;
Sedgwick and Smerdon, 1999). Substitution mutations of residues in
the K1 ANK repeats 1, 2, 3, or 5 results in a non-productive infection of
RK13 cells (Meng and Xiang, 2006), inferring that these residues are
critical for K1's molecular function. To assess if these same residues
were important for K1's eIF2α inhibitory function, p-eIF2α was
detected in lysates from cells infected with viruses expressing mutant
K1 proteins. Studies were focused on mutations in the K1 ANK2
region, a region in which discrete substitution mutations had
identiﬁed residues in the ANK2 region necessary for virus replication
(Meng and Xiang, 2006).
Five recombinant viruses were utilized for this study. For this set of
viruses, wild-type or mutant K1L ORFs were stably introduced into a
WR-based virus lacking both the C7L and K1L ORFs (Meng and Xiang,
2006). Virus vC7L−K1L+ contains a re-inserted wild-type K1L ORF
possessing a V5 epitope tag (Meng and Xiang, 2006). The S2N and S2C
viruses, in contrast, express V5 epitope-tagged K1 proteins with
mutations in the N- or C-terminus of ANK2, respectively (Meng and
Xiang, 2006). S2C#2 and S2C#3 possessed mutations in the C-
terminal region of ANK2, with S2C#2 containingmutations at residues
81, 82, and 84 and S2C#3 containing mutations at residues 86–88
(Meng and Xiang, 2006).
As would be expected, vC7L−K1L− infection rendered the same
phenotype as ΔK1L infection of RK13 cells: eIF2αwas phosphorylated
under these conditions (data not shown). In RK13 cells, the C7L ORF
was not required to inhibit eIF2α phosphorylation: p-eIF2α levels
were comparable in cells infected with a virus lacking only the C7L
ORF (vC7L−K1L+) versus those infected withWR (Figs. 2A and B) and
Fig. 2. The effect of K1L mutations on eIF2α phosphorylation. (A) RK13 cellular
monolayers were mock infected (UN) or infected at an MOI of 10 with (A) ΔK1L, WR,
S2C, S2C#2, or vC7L−K1L+ or (B) ΔK1L, WR, vC7L−K1L+, S2C#2, S2N, or S2C#3. Unless
indicated otherwise, infections proceeded for 4 h pi. Cytoplasmically extracted proteins
were separated by using SDS–12% PAGE and then transferred to PVDF membranes.
Immunoblots were used to detect phosphorylated (top panel) or unmodiﬁed (bottom
panel) forms of eIF2α. Molecular weight markers (MW) are indicated.
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mutant S2C K1 protein, in which nine conserved and non-conserved
amino acid substitution mutations were introduced into the C-
terminal half of the K1L ANK2 region (Meng and Xiang, 2006),
resulted in increased p-eIF2α levels, indicating that these residues
were important for K1 function. P-eIF2α remained detectable if cells
were instead infected with the S2C#2 virus, a virus in which only
ANK2 residues 81, 82, and 84 were substituted (Meng and Xiang,
2006), indicating the importance of these three residues in preventing
eIF2α phosphorylation. In contrast, p-eIF2α levels were greatly
decreased in cells infected with S2C#3, in which residues 86–88 are
mutated (Meng and Xiang, 2006), indicating that these C-terminal
residues were not critical for the K1 inhibitory function. Interestingly,
amino acids in the ANK2 N-terminus were also important for
inhibitory function since p-eIF2α was detected in S2N-infected cells
(Fig. 2B).When comparing these results to residues important for K1's
host-range function (Meng and Xiang, 2006), the samemutations that
altered the K1 host-range function also altered the K1 function of
preventing eIF2α phosphorylation in RK13 cells. Unmodiﬁed eIF2α
was present in similar amounts for each immunoblotted sample,
indicating that the variation observed in p-eIF2α levels was not due to
uneven protein loading of gels.Fig. 3. E3 and K1 product levels in virus-infected RK13 cells. Cellular monolayers were mock
12 h pi, cells were harvested and immunoblotted lysates were probed with antiserum recogn
epitope-tagged K1 products by incubating the immunoblot with anti-K1 antiserum. The m
conﬁrmed by probing the same membrane with anti-actin antiserum. Molecular weight maVirus-induced eIF2α phosphorylation occurs despite vaccinia E3 protein
expression
The K1L ORF is required for a productive vaccinia infection of RK13
cells (Perkus et al., 1990). If the K1L ORF is absent, there is a reduction
in viral and cellular protein synthesis, with little nascent protein
synthesis detected at 2 h pi (Ramsey-Ewing and Moss, 1996). Under
this condition, there may be little to no expression of the vaccinia E3
product, a protein that binds to double-stranded RNA to prevent PKR
activation and subsequent eIF2α phosphorylation (Chang et al.,
1992). Thus, one concern was that eIF2α phosphorylation in ΔK1L-
or S2C#2-infected RK13 cells was due to the absence of E3 proteins
and not to an inherent inhibitory biochemical property of the K1
product.
To investigate this possibility, E3 protein levels were detected in
virus-infected cells by using immunoblotting, probing membranes
with antiserum recognizing the E3 protein (Weaver et al., 2007). E3
proteins were synthesized and stable during RK13 infection since E3
proteins were detected in all infected cells at all times measured pi, as
was evidenced by the presence of a 25-kDa band (Fig. 3). Thus, it was
unlikely that virus-mediated eIF2α phosphorylation was due to the
absence of E3 proteins. Other vaccinia early proteins (M2 and J3) were
also detected in ΔK1L-infected cells (data not shown), suggesting that
ΔK1L infection allows for the synthesis of other early gene products. In
comparison to WR- or vC7L-K1L+-infected cells, it should be noted
that E3 proteins were reduced in ΔK1L- and S2C#2-infected RK13
cells (Fig. 3). Detection of similar levels of actin for each sample
indicated that the differences observed for E3 protein expression was
not due to uneven loading of samples.
Wild-type andmutant K1 proteins were expressed in similar levels
in virus-infected cells (Fig. 3), suggesting that the substitution
mutations did not cause gross misfolding of K1 proteins. Whether
these mutations resulted in more subtle changes in protein con-
formation cannot be excluded. However, it should be noted that the
residues altered in the S2C#2 construct were predicted to be residues
located on the surface of the K1 protein, where the mutations were
likely to have the least impact on protein folding (Meng and Xiang,
2006). The K1 products from vC7L−K1L+-infected cells possessed a
higher mobility than those from WR-infected cells, reﬂecting the
presence of a V5 epitope tag (Meng and Xiang, 2006). Mutant S2C#2
proteins, which did not prevent eIF2α phosphorylation (Fig. 2), were
also detected at all times post-inoculation. Similar to a previous
report, this V5 epitope-tagged mutant protein possessed a higher
molecular mobility than its wild-type counterpart (Meng and Xiang,
2006).
As shown in Fig. 3, E3 protein levels were decreased in cells
infected with either ΔK1L or S2C#2, viruses that mediated eIF2α
phosphorylation. To ensure that reduced E3 protein expression was
independent of eIF2α phosphorylation, studies were repeated in RK13
cells stably expressing the vaccinia E3L product (RK13-E3L). As aninfected (UN) or infected with WR, ΔK1L, S2C#2, or vC7L−K1L+ (MOI=10). At 4, 8, or
izing the vaccinia E3 product. The samemembrane was re-probed for unmodiﬁed or V5
obilities of wild-type or mutant K1 proteins are indicated. Equal protein loading was
rkers (MW) are indicated.
Fig. 4. eIF2α phosphorylation in RK13 cells stably expressing the vaccinia E3 product. RK13 or RK13-E3L cellular monolayers were infected with either WR, ΔK1L, vC7L−K1L+, or
S2C#2 at an MOI of 10 PFU/cell. At 4 h post-infection, cells were harvested, and immunoblotted lysates were incubated with antiserum speciﬁc for the active (phosphorylated) form
of eIF2α and then re-probed with antiserum raised against the unmodiﬁed form of eIF2α and the vaccinia E3 protein.
Fig. 5. eIF2α phosphorylation in virus-infected HeLa cells. HeLa cellular monolayers
were mock infected (UN) or infected with vC7L−K1L+, S2C#2, S2C#3, S2C, or S2N at an
MOI=10. Infections proceeded for 4 h pi. Immunoblots containing cytoplasmically
extracted proteins were probed with antiserum recognizing either the phosphorylated
(top panel) or unmodiﬁed (bottom panel) form of eIF2α. Molecular weight markers
(MW) are indicated.
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induced p-eIF2α levels were decreased as compared with those
observed for similarly treated RK13 cells (data not shown). In contrast
to RK13 cells, E3 protein expression in ΔK1L- or S2C#2-infected cells
remained similar to that observed in infected cells expressing wild-
type K1 proteins in RK13-E3L cells (Fig. 4). Despite the equal E3
protein levels, p-eIF2α remained higher in ΔK1L- or S2C#2-infected
RK13-E3L cells as compared with WR- or vC7L−K1L+-infected RK13-
E3L cells, at all times pi measured, suggesting that E3 protein levels
did not dictate eIF2α phosphorylation. As a control, regular RK13 cells
were infected and processed in parallel with RK13-E3L cells (Fig. 4).
As would be expected, p-eIF2α levels were increased in regular
cells infected with either ΔK1L or S2C#2 compared with WR or
vC7L−K1L+, similar to results shown in Fig. 2.
The K1 product inhibits virus-induced eIF2α phosphorylation in the
human HeLa cell line
Continued studies of the K1 molecular function in RK13 cells
were difﬁcult due to the paucity of reagents that are biologically
reactive with rabbit proteins. Thus, similar experiments were
performed in human cells, in which more reagents are available.
The HeLa cell line was chosen for further study since the K1L ORF
acts as a host-range gene in this cell line (Perkus et al., 1990). In
contrast to RK13 cells, in which removal of the K1L ORF is sufﬁcient
to inhibit vaccinia replication, in HeLa cells, the K1L host-range effect
is only observed in the absence of the C7L ORF (Perkus et al., 1990).
The C7 product was also reported to inhibit eIF2α phosphorylation
(Najera et al., 2006). Thus, studies performed in these cells required
viruses that lacked the C7L ORF (Meng and Xiang, 2006).
Recombinant viruses expressing wild-type or mutant K1 proteins
used for the above studies in RK13 and RK13-E3L cells indeed lacked
the C7L ORF (Meng and Xiang, 2006), enabling us to evaluate the
role of the K1 protein in the absence of C7L gene expression in HeLa
cells. Studies comparing p-eIF2α in MVA versus MVA/K1L-infectedcells were not performed using HeLa cells. MVA infection of HeLa
cells does not result in eIF2α phosphorylation (Najera et al., 2006).
Thus, MVA/K1L infection of HeLa cells would result in the same
phenotype as MVA-infected cells.
eIF2α phosphorylation was examined in virus-infected HeLa cells,
and p-eIF2α was detected by using immunoblotting. Results are
shown in Fig. 5. In HeLa cells, unmodiﬁed eIF2αwas present in mock-
infected cells or in cells infected with a virus containing the wild-type
K1L ORF (vC7L−K1L+). The K1 ANK2 C-terminus was responsible for
the inhibitory phenotype since p-eIF2α was detected in HeLa cells
infectedwith S2C, but not S2N. Of note, infection of HeLa cells with the
S2N virus rendered a different eIF2α phenotype than observed with
RK13 cells: the mutant S2N protein prevented eIF2α phosphorylation
in HeLa cells at 4 h pi (Fig. 5) or at 6 h pi (data not shown). In contrast,
infection of RK13 cells with S2N no longer inhibited this action
(Fig. 2B). Upon further analysis of ANK2 C-terminal region, ANK2
residues 81, 82, and 84 were important for inhibiting eIF2α
phosphorylation since S2C#2 infection resulted in eIF2α
Fig. 6. E3 protein levels in virus-infected HeLa cells. Cellular monolayers were mock
infected (UN) or infected with ΔK1L, WR, S2C#2, or vC7L−K1L+ (MOI=10). At 4, 8, or
12 h post-infection, cells were processed, and immunoblots were probed with
antiserum recognizing the vaccinia E3 product. The same membrane was re-probed
for K1 products by incubating the immunoblot with anti-K1 antiserum. Molecular
weight markers (MW) are indicated.
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infection correlated with a replication-defective phenotype in HeLa
cells (Meng and Xiang, 2006).
Inhibition of virus-induced eIF2α activation in HeLa cells is independent
of E3 protein expression
As with RK13 cells, it was important to eliminate the possibility
that eIF2α phosphorylation was due to a lack of E3 protein synthesis
in virus-infected HeLa cells. Thus, E3 proteins were detected in
vaccinia virus-infected HeLa cells by using immunoblotting, similar to
experiments shown in Fig. 3. Similar to results with RK13 cells, E3
proteins were detected at early and late times post-infection, in all
virus-infected cells, suggesting that eIF2α phosphorylation was not
due to an absence of E3 proteins (Fig. 6). It was noted that E3 protein
levels, while detectable, were lowest in cells infected with S2C#2, a
virus that did not prevent eIF2α activation in HeLa cells (Fig. 6).
Although it cannot be ruled out that the decreased E3 protein levels
are responsible for eIF2α phosphorylation, data from Figs. 3 and 4
would indicate that E3 protein levels are independent of the K1
phenotype in HeLa cells. Mutant and wild-type K1 proteins were
detected in fairly similar amounts in infected cells (Fig. 6). Thus, the
reduction in E3 protein levels did not appear to be due to K1 protein
synthesis or stability. As before, the V5 epitope-tagged K1 products
expressed in vC7L−K1L+- or S2C#2-infected cells possessed a higher
mobility than wild-type K1 products expressed during WR infection
(Fig. 6).
The PKR protein is responsible for activating eIF2α in vaccinia
virus-infected cells
Several cellular proteins are known to activate eIF2α, including
PKR, PERK, GCN2, and HRI (Proud, 2005). Commonly, PKR is
responsible for eIF2α phosphorylation during virus infection, thus
we assessed if the PKR protein was responsible for eIF2α activation in
vaccinia virus-infected cells. To this end, we assessed virus-induced
eIF2α phosphorylation in HeLa cells in which N95% of PKR protein
expression is stably silenced (Zhang et al., 2008). This cell line isFig. 7. The effect of decreased PKR protein levels on eIF2α phosphorylation in virus-infecte
infected (UN) or infected with either vC7L−K1L+, S2C#2, S2C#3, S2C, or S2N (MOI=10
recognizing either the phosphorylated or unmodiﬁed forms of eIF2α. The same immunobl
(MW) are indicated.referred to as PKRkd. Similar to previous studies (Zhang et al., 2008),
PKR proteins were either undetectable or greatly reduced in lysates
from PKRkd cells versus normal HeLa cells, regardless of whether cells
were mock infected or infected (Fig. 7). The decrease in PKR proteins
did not grossly affect eIF2α protein stability since eIF2α was present
in similar amounts in PKRkd versus HeLa cells. P-eIF2α levels were
greatly decreased when PKRkd cells were infected with viruses that
normally allowed for eIF2α activation in parental HeLa cells, such as
S2C#2 and S2C, inferring that PKR proteins were required for virus-
mediated eIF2α phosphorylation. Equally important, eIF2α remained
unmodiﬁed in vC7L−K1L+-, S2C#3-, and S2N-infected PKRkd cells, as
would be expected.
The K1 function of preventing virus-mediated PKR activation is not
related to its host-range function in HeLa cells
It was noticed that only K1-expressing viruses that inhibited
eIF2α phosphorylation allowed for a productive infection in RK13
and HeLa cells (Meng and Xiang, 2006). These data suggested that a
block in eIF2α phosphorylation, which would allow for translation
initiation, is the K1 mechanism for allowing a productive infection. If
this is the appropriate mechanism, then PKR-deﬁcient cells should
lack a mechanism to phosphorylate eIF2α and should be permissive
for virus replication, regardless of the absence of a functional K1
product. To test this, we detected viral protein synthesis in HeLa
cells lacking PKR proteins (PKRkd), comparing the phenotypes to
virus growth in normal HeLa cells possessing functional PKR proteins
(Fig. 8A). The infection of HeLa cells with S2C#2, a virus unable to
replicate in HeLa cells (Meng and Xiang, 2006), resulted in the
dramatic decrease of viral protein synthesis at 4 and 24 h pi. In
PKRkd cells infected with S2C#2, modest levels of protein synthesis
were still observed at 4 and 24 h pi, suggesting that the elimination
of PKR indeed allowed for some viral protein synthesis. For either
cell line, viral protein expression was observed during infection with
either vC7L–K1L+ or S2C#2. When detecting an individual early (E3)
or late (L1) protein under these same conditions, E3 proteins were
still detected (Fig. 8B). In contrast, L1 proteins were no longer
detected in S2C#2-infected PKRkd cells, suggesting that the elimina-
tion of PKR, while allowing for partial restoration of viral protein
synthesis, was not sufﬁcient for allowing robust expression of viral
late proteins. Due to the lack of late protein synthesis, no visible
plaques were observed in PKRkd monolayers infected with S2C#2 (or
S2C; Fig. 8C). The recombinant viruses also express a GFP gene under
the control of the p11 late promoter (Meng and Xiang, 2006),
allowing for the visualization of individual plaques by ﬂuorescent
microscopy. In agreement with data from Fig. 8C, no GFP-expressing
plaques were observed for PKRkd cells infected with S2C#2 (Fig. 8D).
The WR, vC7L-K1L+, S2C#3, and S2N viruses maintained their
abilities to replicate in PKRkd cells, as evidenced by the presence of
microscopic (Fig. 8C) and visual (Fig. 8D) plaques. GFP-expressing
plaques formed during vC7L-K1L+, S2C#3, or S2N infections were
noticeably smaller in PKRkd versus normal HeLa monolayers.d HeLa cells. HeLa cells expressing PKR (HeLa) or lacking PKR (kd) were either mock
). At 4 h pi, cells were harvested and subjected to immunoblotting with antiserum
ot was probed with antiserum speciﬁc for the PKR protein. Molecular weight markers
Fig. 8. Virus plaque formation in HeLa cells expressing or lacking PKR proteins. HeLa
cellular monolayers either expressing PKR proteins (HeLa) or deﬁcient for PKR proteins
(PKRkd) were infected with the indicated viruses at an MOI of (A and B) 10 or (C and D)
0.01 PFU/cell. (A) At 30 min before harvesting, infected cellular monolayers were
incubated in medium containing 35[S]-methionine and 35[S]-cysteine. Cells were
collected and lysed, and an equal volume of each lysates was separated by SDS–10%
PAGE. Dried gels were imaged by using phosphorimaging. (B) Infected HeLa or PKRkd
cells were collected at the times indicated and lysed in CE buffer. Lysates were analyzed
by SDS–12% PAGE, and proteins were transferred to PVDF membranes. Immunoblots
were probed with antiserum recognizing either the L1 or E3 vaccinia proteins.
Molecular weight markers (MW) are indicated. (C) At 48 h post-infection, media were
replaced with a 20% ethanol solution that contained 1% crystal violet. After a 10-min
incubation, supernatants were removed and plates were air dried. (D) GPF-expressing
infected cells were detected by using ﬂuorescence microscopy at 48 h pi.
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its ability to inhibit eIF2α phosphorylation
For PKR to become activated, it forms a dimer, resulting in its auto-
phosphorylation (Garcia et al., 2007). We observed that the K1
protein prevented eIF2α phosphorylation. There were two likely
mechanisms responsible for this phenotype. First, the K1 protein may
interact with eIF2α, thereby preventing activated PKR from phos-
phorylating eIF2α. Alternatively, the K1 protein may prevent PKR
auto-phosphorylation as its mechanism for inhibition. To test the later
possibility, we assessed if the K1 product prevented PKR activation.
HeLa cells were infected with viruses expressing wild-type or mutant
K1 proteins, and PKR activation was assessed by detecting the
phosphorylated (activated) form of PKR by using immunoblotting.
Wild-type K1L proteins prevented PKR activation, as judged by the
absence of p-PKR (Fig. 9). This function was also detected in cells
infected with mutant viruses that inhibited eIF2α phosphorylation
(S2C#3 and S2N), suggesting that the K1 protein affected the ability of
PKR to auto-phosphorylate. Conversely, PKR was activated when cells
were infected with either S2C#2 or S2C, viruses that no longer
inhibited eIF2α phosphorylation. Anti-PKR antiserum that simulta-
neously recognizes the modiﬁed and unmodiﬁed PKRs was used to
detect similar PKR levels in each well. Interestingly, although
activated PKR was present in S2C#2- and S2C-infected cells, a
population of inactive PKR proteins was also detected.
Discussion
Here, we report a novel function for the vaccinia K1 protein; it
inhibits PKR activation. Since active PKR attenuates protein synthesis,
one attractive hypothesis was that the K1 protein, in preventing PKR
activation, would allow for virus replication in RK13 and HeLa cells.
This model was bolstered by the observation that viruses that allowed
PKR or eIF2α activation were not replication competent in HeLa or
RK13 cells (Meng and Xiang, 2006), respectively. While PKR-deﬁcient
HeLa cells indeed allowed for a partial restoration of viral protein
synthesis, these cells remained unable to support the synthesis of the
late L1 protein or the replication of S2C#2. Thus, K1's PKR inhibitory
phenotype only partially contributes to permissivity in HeLa cells. One
conclusion from this study is that there are PKR-independent
mechanisms for controlling viral protein synthesis during infection.
For example, for translation to occur, capped mRNA must be
complexed with eIF4F, a complex that is formed only upon the
inactivation of eIF4E binding proteins. Vaccinia virus infection
inactivates the 4E-BP1 binding protein to promote eIF4F complex
formation. Whether this event is critical to the host-range phenotype
is unknown (Walsh et al., 2008).
The E3 and K3 proteins are expressed early in infection, and each
inhibits PKR activation (Rivas et al., 1998; Romano et al., 1998; Sharp
et al., 1998; Shors et al., 1997).ΔK1L infection of RK13 cells results in a
dramatic decrease in early gene translation (Ramsey-Ewing andMoss,
1996), which would presumably include E3 and K3 protein synthesis.
Thus, an initial concern was that the ΔK1L effect in these rabbit cells
was indirect due to a lack of E3 and K3 proteins. However, we found
that E3 proteins were expressed in RK13 cells, regardless of the
absence of the K1L ORF. Further examination revealed that other early
proteins, such as the M2 and J3 products, were also detected in ΔK1L-
infected RK13 cells (data not shown), suggesting that the K3 protein
would also be synthesized during infection as well. Since early protein
synthesis, as measured by the 35S-methionine metabolic labeling of
nascent proteins during virus infection, was detected for at least 1 h
after ΔK1L infection of RK13 cells (Ramsey-Ewing and Moss, 1996),
our results were not surprising. Most important, these data indicate
that the PKR activation phenotype in ΔK1L-infected RK13 cells is not
indirect; that is, PKR activation in ΔK1L-infected cells is not simply
due to a lack of E3, or other known or undiscovered, PKR inhibitoryproteins. For HeLa cells, infection with viruses lacking both the K1L
and the C7 L ORFs results in a block in intermediate gene translation
(Hsiao et al., 2004). Thus, E3 (and K3) proteins are expected to be
synthesized, an event we detect in our system.
We identiﬁed that the ANK2 repeat of K1 is responsible for PKR
inhibitory function but cannot rule out that other K1 ANK repeats may
also possess inhibitory function. Given that other ANK repeats of K1
are important for its host-range function (Meng and Xiang, 2006), one
prediction is that mutations in other ANK repeats would be expected
Fig. 8 (continued).
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studies to the ANK2 region since the smallest number of amino acid
substitutions was made in this repeat (Meng and Xiang, 2006).
Further, two of these constructs (S2C#2 and S2C#3) yielded different
host-range phenotypes, characteristics that would enable us to easily
assess if PKR activity and host-range phenotype were related.
ANK repeats are 33 residues in length, and the motif is deﬁned as a
β-hairpin–helix–loop–helix structure (Sedgwick and Smerdon, 1999).
These motifs are found in proteins in nearly all phyla and have myriad
functions (Sedgwick and Smerdon, 1999). Diversity in binding
partners for ANK-containing proteins is attained by variation in the
surface residues of ANK repeats and by the number of ANK repeats
stacked together to form a stable structure (Sedgwick and Smerdon,
1999). Substitution mutations were originally made in the ANK2Fig. 9. The effect of virus infection on PKR activation. HeLa cell monolayers were mock
infected (UN) or infected with either vC7L−K1L+, S2C#2, S2C#3, S2C, or S2N at an MOI
of 10. At 4 h post-infection, cells were harvested, prepared for immunoblotting and
probed with antiserum recognizing either the phosphorylated form of PKR (p-PKR) or
the unmodiﬁed form. Molecular weight markers (MW) are indicated.region that would only affect surface residues, affecting potential
binding site for K1 interacting partners but allowing for the ANK
repeat to keep its structure, since structure is likely important for its
ability to interact with its target protein (Meng and Xiang, 2006). The
mutated residues in S2C#2 lie in the outer helix, a potential surface for
protein–protein interactions, while the mutations in S2C#3 lie
downstream of the outer helix (Meng and Xiang, 2006). Thus, the
ﬁnding that the S2C#2 virus allowed for PKR activation likely reﬂects a
loss of binding to a target protein. A previous study identiﬁed a rabbit
homolog of the human cellular ACAP2 protein that interacts with K1
protein in vaccinia-infected RK13 cells (Bradley and Terajima, 2005).
Whether K1-ACAP2 interactions are critical for its ability to inhibit
PKR activity is an area of future research. It was noticed that the ANK2
regions responsible for PKR inhibition were different for RK13 versus
HeLa cells. For RK13 cells, residues in both the N and C-terminal
portion of ANK2 were necessary for inhibitory function, while
residues only in the C-terminal portion of ANK2 were important for
HeLa cells. These differences may indicate that the K1 protein
interacts with a different subset of rabbit versus human proteins.
While activated PKR is best known for its anti-viral effect of
inhibiting protein synthesis, it possesses other biological properties
that neutralize virus infections (Garcia et al., 2007). For example, PKR
also induces apoptosis, a rapid form of cell death that eliminates virus-
infected cells (Lee and Esteban, 1994). Whether the K1 protein would
prevent PKR-induced apoptosis is unknown. PKR also activates the
NF-κB transcription factor (Maran et al., 1994; Yang et al., 1995). Since
this cellular transcription factor induced the expression of anti-viral
immune molecules, this property of PKR could also inhibit virus
replication. To date, there are multiple vaccinia proteins that inhibit
PKR activity, including K1, C7, E3, and K3 (Garcia et al., 2007). For this
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E3L or the K3L ORF, both of which are present and presumably
expressed during virus infection, are involved in virus-mediated PKR
activation. These data would argue that molecules in addition to
dsRNA, including PACT and Mda7, activate PKR during poxvirus
infection. Furthermore, the presence ofmyriad vaccinia proteins likely
reﬂect the fact that different insults activate PKR.
The CP77, K1, and C7 proteins can functionally complement each
other to allow for a productive vaccinia infection in HeLa cells (Perkus
et al., 1990). These three proteins also prevent PKR activation (Meng
et al., 2008; Hsiao et al., 2004). The K1 and CP77 proteins both possess
ankyrin repeats. The CP77 protein also has an F-boxmotif (Chang et al.,
2009), a motif lacking in the K1 protein. In contrast, no obvious F-box
or ankyrin motifs are present in C7 proteins. One prediction, then, is
that the CP77 and K1 proteins will utilize similar molecular mechan-
isms to alter PKR activation, while the C7 product will likely utilize a
mechanism distinct from CP77 or K1. As shown here, the K1 protein
prevents PKR activation, as measured by an inhibition of PKR
phosphorylation. The K1 protein lacks an obvious dsRNA binding
motif, making it unlikely that K1 functions like the E3 protein, binding
to dsRNA as its mechanism to inhibit PKR activation. A simple
explanation for K1's molecular mechanism is that the K1 protein
binds to PKR, preventing its dimerization and subsequent auto-
phosphorylation. Ankyrin repeats, like the ones present in K1, are
important for mediating protein–protein interactions (Bork, 1993),
making it reasonable to suggest that the K1 protein could form a stable
complex with PKR. A second possibility is that the K1 protein indirectly
inhibits PKR activation by binding to cellular PKR activating proteins, such
as PACT and Mda7 (Garcia et al., 2007; Zhang et al., 2009). Thus, future
directions include assessing K1 interactions with the above proteins and
assessing if K1 binding function correlates with PKR inhibition.
Materials and methods
Cells and viruses
Human cervical carcinoma HeLa or rabbit kidney epithelial (RK13)
cells were obtained from the American Type Culture Collection. RK13
cells stably expressing the vaccinia E3L product (RK13-E3L) were
obtained from Dr. Bertram Jacobs (Department of Microbiology,
Arizona State University). HeLa cells in whichmore than 95% of PKR is
stably knocked down (PKRkd) were obtained from Dr. Charles Samuel
(Department of Molecular, Cellular and Developmental Biology,
University of California, Santa Barbara; Zhang et al., 2008). These
cells stably express short hairpin RNA speciﬁc for PKR mRNA. All cell
lines weremaintained in DMEM containing 10% fetal calf serum (FCS).
PKRkd cells were maintained in medium supplemented with 1 μg/ml
puromycin (Sigma-Aldrich).
The wild-type Western Reserve (WR) strain of vaccinia virus and
the attenuated modiﬁed vaccinia Ankara (MVA) strain were used in
these studies. Virus construct MVA/K1L contains the wild-type K1L
ORF and its natural promoter stably inserted into the MVA genome
(Shisler and Jin, 2004). Virus ΔK1L was created by replacing the K1L
ORF of WR with the Escherichia coli gpt gene via homologous
recombination (Shisler and Jin, 2004). WR and ΔK1L viruses were
ampliﬁed in BSC-1 cells, while MVA-based viruses were ampliﬁed in
chicken embryo ﬁbroblasts (Charles Rivers Laboratories).
Five recombinant viruses containing stably re-introduced wild-
type or mutated K1L ORFs were used in these studies: vC7L−K1L+,
S2N, S2C, S2C#2, and S2C#3, and their construction was described
previously (Meng and Xiang, 2006). The parent virus for each of these
viruses was vC7L−K1L−, in which the C7L and K1L ORFs were deleted
from the WR genome. For the creation of vC7L−K1L+, a cassette
containing the V5 epitope-tagged K1L ORF and its natural promoter
and an adjacent green ﬂuorescing protein (GFP) gene under control of
the P11 late promoter were stably re-inserted into vC7L−K1L− (Mengand Xiang, 2006). Thus, cells infected with these viruses also express
GFP. Virus S2N was created similarly, except that ankyrin repeat 2 of
the K1L ORF was mutated at residues 63, 67, and 70–75 and then
inserted into vC7L−K1L− (Meng and Xiang, 2006). S2C is a virus that
codes for a mutated K1 product, in which the ankyrin repeat 2 C-
terminal residues 78, 79, 82, 83, 85, and 87–90 are mutated (Meng
and Xiang, 2006). Viruses S2C#2 and S2C#3 express mutant K1L
product in which residues 81, 82, and 84 or 86–88 are mutated,
respectively (Meng and Xiang, 2006). These recombinant viruses
were ampliﬁed in Vero cells.
Immunoblot analysis
Cytoplasmic extracts were collected according to a modiﬁed
protocol described previously (Shisler and Jin, 2004). Conﬂuent
monolayers of cells in 6-well tissue culture dishes were infected
with the indicated viruses at an MOI of 10, with an absorption
incubation for 60 min in DMEM containing 2.5% FCS. At the times
indicated post-infection, cellular monolayers were dislodged from
their wells by scraping, and cells were collected by centrifugation
(30 s at 14,000×g). As a positive control for eIF2α phosphorylation, a
separate set of mock-infected RK13 cells was incubated in medium
containing 10 μM thapsigargin (Sigma-Aldrich) for 4 h before cells
were collected by scraping. Cellular pellets were resuspended and
lysed in cytoplasmic extraction buffer (CE) that contained the HALT
protease inhibitor cocktail (Pierce) for 5 min at 4 °C. After a brief
centrifugation (30 s at 14,000×g), the resultant supernatants were
collected and transferred to new microfuge tubes. The protein
concentration of each sample was determined using the bicinchoninic
acid (BCA) assay (Pierce). An equal amount of protein (20 μg) from
each sample was mixed with 5× non-reducing lane marker (Thermo
Scientiﬁc) for a ﬁnal 1× concentration that contained 5% 2-
mercaptoethanol (Fisher Scientiﬁc), boiled for 5 min, and incubated
on ice brieﬂy. Next, proteins were electrophoretically separated by
using SDS–12% PAGE. Following electrophoresis, proteins were
transferred to a polyvinyl diﬂuoride (PVDF) membrane (Millipore),
and membranes were incubated for 1 h in TBS containing 0.05%
Tween-20 (TTBS) and 5% non-fat milk. Next, membranes were
incubated at 4 °C overnight in primary antiserum in TTBS containing
5% non-fat milk. The following primary antibodies were used: rabbit
monoclonal anti-phospho-eIF2α S51 (1:500; Epitomics), rabbit
monoclonal anti-eIF2α (1:1,000; Santa Cruz), rabbit anti-phospho
PKR T446 (1:1,000; Epitomics), rabbit monoclonal anti-PKR N-
terminus (1:1,000; Epitomics), mouse monoclonal anti-E3L antibody
(1:1,000; a gift from Dr. Stuart Isaacs, School of Medicine, University
of Pennsylvania; Weaver et al., 2007), mouse monoclonal anti-L1R
antibody (1:1,000; a gift from Dr. Jay Hooper, Virology Division,
United States Army Medical Research Institute for Infectious Disease,
Fort Detrick, Maryland), rabbit polyclonal anti-K1L antiserum (1:500),
or rabbit anti-actin antiserum (1:1,000; Sigma-Aldrich). Immunoblots
were washed in TTBS and incubated in a TTBS solution containing
either goat-anti-rabbit immunoglobulin G (IgG; 1:10,000) or goat-
anti-mouse IgG conjugated with horseradish peroxidase (1:10,000;
Fischer Scientiﬁc). Immunoblots were developed using SuperSignal
West chemiluminescence reagents per the manufacturer's directions
(Pierce).
Detection of GFP-expressing viruses and plaque phenotypes
Conﬂuentmonolayers of HeLa or PKRkd cells in 6-well issue culture
plates were infected at an MOI of 0.01 PFU/cell of either WR,
vC7L−K1L+, S2N, S2C, S2C#2, or S2C#3. At 48 h post-infection, GFP-
expressing plaques were detected and visualized and photographed
by using an inverted ﬂuorescence microscope (Olympus, 4× objec-
tive). Following the microscopic examination of infected cellular
monolayers, supernatants were removed from monolayers, and 2 ml
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each well. After a 5-min incubation, the solution was removed and
plates were air-dried to visualize virus plaques.
35S-methionine labeling of virus-infected cells
Conﬂuent monolayers of HeLa or PKRkd cells in 6-well tissue
culture plates were mock infected or infected at an MOI of 10 PFU/cell
with either vC7L–K1L+ or S2C#2. Thirty minutes before harvesting,
each well was washed twice with DMEM lacking methionine and
cysteine (DMEMMet-Cys−; Hyclone) and subsequently replenished
with 0.5 ml of DMEMMet-Cys− containing 75 μCi EXPRE35S35S
protein labeling mix (Perkin Elmer). Cells were harvested at 0.5, 2, 4,
and 24 h post-infection by scraping and collected by centrifugation.
Pelleted cells were lysed in CE buffer as described above. Equal
volumes of clariﬁed lysates were analyzed by using 10% SDS–PAGE.
Gels were dried in a gel drier and exposed to phosphoimager screens,
and images were developed by using phosphoimaging.
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